Financial statements Master Pharm
Cash inflows of MASTER PHARM
|
Year
|
2022
|
2023
|
|---|---|---|
| Net cash from operating expenses | 6 971 848,17 | 2 998 610,33 |
| Net cash flow from investing activities | -1 305 900,75 | 9 592 399,76 |
| Net cash flow from financial activities | -4 889 328,52 | -12 129 915,58 |
| Total net cash flow | 776 618,90 | 461 094,51 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.